Top

Published in:

01-02-2016 | Original Research

Attitudes and Knowledge of Maternal-Fetal Medicine Fellows Regarding Noninvasive Prenatal Testing

Authors: Paul Swaney, Emily Hardisty, Lauren Sayres, Samantha Wiegand, Neeta Vora

Published in: Journal of Genetic Counseling | Issue 1/2016

Abstract

Using cell-free DNA in maternal serum to detect fetal aneuploidy has been shown to have high sensitivity and specificity. The purpose of this study was to assess attitudes and knowledge of Maternal-Fetal Medicine (MFM) fellows regarding noninvasive prenatal testing (NIPT). A 13 question survey was sent via listserv to US-based MFM fellows. One hundred sixteen fellows responded, a 42.3 % response rate, with >75 % reporting they are comfortable ordering NIPT. Most (82 %) preferred that a patient discuss options with a provider or genetic counselor. Three common methods used to learn about NIPT were: formal educational activities (n = 78, 69 %), self-review of the literature (n = 76, 67 %), and discussions with peers (n = 73, 65 %). On questions related to trisomy 21, accuracy was >70 %. However, accuracy was lower regarding use in twin pregnancies (42 %) and monosomy X screening (50 %).

American College of Obstetricians and Gynecologists Committee on Genetics. Committee opinion no. 545. (2012). Noninvasive prenatal testing for fetal aneuploidy. Obstetrics and Gynecology, 120(6), 1532–1534.CrossRef

Benn, P. A., & Chapman, A. R. (2010). Ethical challenges in providing noninvasive prenatal diagnosis. Current Opinion in Obstetrics and Gynecology, 22(2), 128–134.CrossRefPubMed

Bianchi, D. W., Platt, L. D., Goldberg, J. D., Abuhamad, A. Z., Sehnert, A. J., Rava, R. P., et al. (2012). Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstetrics and Gynecology, 119(5), 890–901.CrossRefPubMed

Bianchi, D. W., Prosen, T., Platt, L. D., Goldberg, J. D., Abuhamad, A. Z., Rava, R. P., et al. (2013). Massively parallel sequencing of maternal plasma DNA in 113 cases of fetal nuchal cystic hygroma. Obstetrics and Gynecology, 121(5), 1057–1062.CrossRefPubMed

Bianchi, D. W., Parker, R. L., Wentworth, J., Madankumar, R., Saffer, C., Das, A. F., et al. (2014). DNA sequencing versus standard prenatal aneuploidy screening. New England Journal of Medicine, 370(9), 799–808.CrossRefPubMed

Brierley, K. L., Blouch, E., Cogswell, W., Homer, J. P., Pencarinha, D., Stanislaw, C. L., et al. (2012). Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications. Cancer Journal, 18(4), 303–309.CrossRef

Madan, K., & Breuning, M. H. (2014). Impact of prenatal technologies on the sex ratio in India: an overview. Genetics in Medicine, 16(6), 425–32.PubMedCentralCrossRefPubMed

Palomaki, G. E., Kloza, E. M., Lambert-Messerlian, G. M., Haddow, J. E., Neveux, L. M., Ehrich, M., et al. (2011). DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genetics in Medicine, 13(11), 913–920.CrossRefPubMed

Plon, S. E., Cooper, H. P., Parks, B., Dhar, S. U., Kelly, P. A., Weinberg, A. D., et al. (2011). Genetic testing and cancer risk management recommendations by physicians for at-risk relatives. Genetics in Medicine, 13(2), 148–154.PubMedCentralCrossRefPubMed

Sayres, L. C., Allyse, M., Norton, M. E., & Cho, M. K. (2011). Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation. Prenatal Diagnosis, 31(11), 1070–1076.PubMedCentralCrossRefPubMed

Selkirk, C. G., Weissman, S. M., Anderson, A., & Hulick, P. J. (2013). Physicians’ preparedness for integration of genomic and pharmacogenetic testing into practice within a major healthcare system. Genetic Testing and Molecular Biomarkers, 17(3), 219–225.CrossRefPubMed

Vora, N. L., & O’Brien, B. M. (2014). Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: Proceed with caution. Obstetrics and Gynecology, 123(5), 1097–1099.CrossRefPubMed

Wapner RJ, Babiarz JE, Levy B, et al. (2015) Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes. American journal of obstetrics and gynecology, 212(3): 332.e1-9

You, Y., Sun, Y., Li, X., Li, Y., Wei, X., Chen, F., et al. (2013). Integration of targeted sequencing and NIPT into clinical practice in a Chinese family with maple syrup urine disease. Genetics in Medicine, 16, 594–600.CrossRef

Title: Attitudes and Knowledge of Maternal-Fetal Medicine Fellows Regarding Noninvasive Prenatal Testing
Authors: Paul Swaney
Emily Hardisty
Lauren Sayres
Samantha Wiegand
Neeta Vora
Publication date: 01-02-2016
Publisher: Springer US
Published in: Journal of Genetic Counseling / Issue 1/2016
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-015-9844-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Attitudes and Knowledge of Maternal-Fetal Medicine Fellows Regarding Noninvasive Prenatal Testing

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2016

Non-invasive Prenatal Diagnosis for BRCA Mutations – a Qualitative Pilot Study of Health Professionals’ Views

“Is It Worth Knowing?” Focus Group Participants’ Perceived Utility of Genomic Preconception Carrier Screening

Experiences of Women Who Underwent Predictive BRCA 1/2 Mutation Testing Before the Age of 30

Comparison of Informed Consent Preferences for Multiplex Genetic Carrier Screening among a Diverse Population

Communication of Psychiatric Risk in 22q11.2 Deletion Syndrome: A Pilot Project

“Not Tied Up Neatly with a Bow”: Professionals’ Challenging Cases in Informed Consent for Genomic Sequencing